Yue Ma

机构：Harbin Engineering University, Harbin Medical University, Peking University, Peking University Cancer Hospital, Third Affiliated Hospital of Harbin Medical University, Second Affiliated Hospital of Harbin Medical University · ORCID：0009-0002-6368-2806

发表论文 8 篇 · 总被引 56 次 · h-index 4

代表论文

• Cetuximab-conjugated perfluorohexane/gold nanoparticles for low intensity focused ultrasound diagnosis ablation of thyroid cancer treatment (2020 · Science and Technology of Advanced Materials · 被引 18)
• Quercetin alleviates postmenopausal atherosclerosis by suppressing endothelial cell ferroptosis via regulating the KEAP1/NRF2/GPX4 signalling pathway (2025 · British Journal of Pharmacology · 被引 14)
• A multicenter, phase 1 study of AB011, a recombinant humanized anti-CLDN18.2 monoclonal antibody, as monotherapy and combined with capecitabine and oxaliplatin (CAPOX) in patients with advanced solid tumors. (2023 · Journal of Clinical Oncology · 被引 13)
• An integrated prognosis prediction model based on real-word clinical characteristics for immunotherapy in advanced esophageal squamous cell carcinoma (2025 · Cancer Immunology Immunotherapy · 被引 5)
• Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study (2024 · Cancer Immunology Immunotherapy · 被引 2)
• Cetuximab-Conjugated Perfluorohexane/Gold Nanoparticles for Low Intensity Focused Ultrasound Diagnosis Ablation of Thyroid Cancer Treatment (2020 · Research Square · 被引 2)